Operating Segments (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Summary of segmental information
Revenues	$ 1,544,964	$ 1,725,545	$ 2,689,752	$ 2,845,318
Income/(Loss) from Operations	(2,164,891)	(1,589,290)	(4,464,954)	(3,983,391)
Amortization and Depreciation Expense	12,932	11,170	22,992	22,384
Interest Income, Net	41,370	32,948	91,130	49,843
Share-Based Compensation	72,892	90,425	152,465	198,395
Identifiable Assets	9,192,963		9,192,963		$ 10,491,702
Public Health Solutions [Member]
Summary of segmental information
Revenues	1,095,865	1,449,044	1,776,218	2,258,300
Income/(Loss) from Operations	204,121	30,299	195,110	(55,906)
Amortization and Depreciation Expense	4,316	4,512	8,718	8,992
Share-Based Compensation	8,072	12,818	13,268	28,486
Identifiable Assets	1,564,020		1,564,020		1,181,114
Specialized BioTherapeutics [Member]
Summary of segmental information
Revenues	449,099	276,501	913,534	587,018
Income/(Loss) from Operations	(1,463,334)	(923,960)	(2,798,891)	(2,445,308)
Amortization and Depreciation Expense	4,168	5,345	8,845	10,729
Share-Based Compensation	19,094	21,898	40,002	50,216
Identifiable Assets	150,782		150,782		78,336
Corporate [Member]
Summary of segmental information
Income/(Loss) from Operations	(905,678)	(695,629)	(1,861,173)	(1,482,177)
Amortization and Depreciation Expense	4,448	1,313	5,429	2,663
Interest Income, Net	39,851	32,948	84,604	49,843
Share-Based Compensation	45,726	$ 55,709	99,195	$ 119,693
Identifiable Assets	$ 7,478,161		$ 7,478,161		$ 9,232,252